Three-Statement Breakdown
Not enough comparable history yet for a verdict.
REVENUE
+6.8%
9,028
GROSS PROFIT
—
—
NET INCOME
-51.4%
573
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
RESTATED · WAS 8,933
|
8,317 | 8,420 | 8,435 | 8,452 | 8,500 | 8,624 | 8,800 | 9,028 | +2.6% | +6.8% |
| SG&A |
RESTATED · WAS (3,381)
|
(3,154) | (3,186) | (3,204) | (3,301) | (3,345) | (3,381) | (3,456) | (3,509) | +1.5% | +6.3% |
| Interest expense |
RESTATED · WAS -15
|
(5) | (9) | (13) | (3) | (9) | (21) | (25) | (29) | +16.0% | +866.7% |
| Income tax |
RESTATED · WAS (274)
|
(230) | (257) | (269) | (275) | (276) | (277) | (301) | (303) | +0.7% | +10.2% |
| Net income |
|
355 | 414 | 487 | 1,180 | 1,173 | 1,151 | 1,137 | 573 | -49.6% | -51.4% |
| EPS (diluted) |
NOT DISCLOSED
|
$0.62 | $0.73 | $0.86 | $2.08 | $2.07 | $2.03 | $2.01 | — | — | — |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-K FILED 2026-08-07 ↗